We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Patterson Companies Inc | NASDAQ:PDCO | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.10 | 0.39% | 25.76 | 25.32 | 27.56 | 25.915 | 25.71 | 25.81 | 873,241 | 01:00:00 |
Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated net sales of $1.55 billion (see attached Sales Summary for further details) in its fiscal third quarter ended January 23, 2021, an increase of 6.5 percent compared to the same period last year. Internal sales, which are adjusted for the effects of currency translation and changes in product selling relationships, increased 6.9 percent.
Reported net income attributable to Patterson Companies, Inc. for the third quarter of fiscal 2021 was $48.8 million, or $0.50 per diluted share, compared to $23.2 million, or $0.24 per diluted share, in the third quarter of fiscal 2020. Adjusted net income1 attributable to Patterson Companies, Inc., which excludes deal amortization, integration and business restructuring expenses, legal reserve costs and accelerated debt-related costs totaled $55.8 million for the third quarter of fiscal 2021, or $0.58 per diluted share, compared to $44.5 million in the same quarter of fiscal 2020, or $0.47 per diluted share. The 25.3 percent year-over-year increase in adjusted net income for the period is primarily attributed to strong sales execution, improved operating margins across both business segments, and the benefit of continued expense discipline during the fiscal 2021 third quarter.
“Patterson’s third quarter results demonstrate the continued focus and dedication of our team to help drive the success of our customers as we navigate the ongoing disruption of the pandemic,” said Mark Walchirk, President and CEO of Patterson Companies. “Our commitment to strong execution and operational excellence, combined with our ongoing investments to broaden and enhance our value proposition, has enabled us to build additional momentum across our entire business – including increased sales and margin expansion in both our Dental and Animal Health segments during the third quarter.
“We grew adjusted EPS by 23 percent through the continued focus on improving our performance and creating value for our shareholders. Looking ahead, we remain confident about our strengthened position in each of our end markets and in Patterson's long-term value creation potential.”
Patterson Dental
Reported net sales in our Dental segment for the third quarter of fiscal 2021, which represented approximately 42 percent of total company sales, were $648.9 million compared to $626.6 million in the third quarter of last year. Internal sales increased 3.6 percent compared to the fiscal 2020 third quarter, including 13.6 percent growth in consumables.
Patterson Animal Health
Reported net sales in our Animal Health segment for the third quarter of fiscal 2021, which comprised approximately 58 percent of the company’s total sales, were $894.3 million compared to $817.3 million in the third quarter of last year. Internal sales for the segment increased 10.0 percent from the fiscal 2020 third quarter with companion animal posting internal sales growth of 20.7 percent compared to the same period one year ago.
Balance Sheet and Capital Allocation
During the first nine months of fiscal 2021, Patterson Companies used $604.9 million of cash from operating activities and collected deferred purchase price receivables of $634.5 million, generating cash of $29.6 million, compared to generating $190.3 million in the first nine months of fiscal 2020. Free cash flow1 (see definition below and attached free cash flow table) generated during the first nine months of fiscal 2021 is down $120.0 million compared to the first nine months of fiscal 2020, primarily due to an increased level of working capital in the current period.
During the third quarter of fiscal 2021, Patterson Companies declared a quarterly cash dividend of $0.26 per share. On a year-to-date basis, Patterson has returned $50.1 million in cash dividends to shareholders.
Year-to-Date Results
Consolidated reported net sales for the first nine months of fiscal 2021 totaled $4.35 billion, a 3.5 percent year-over-year increase. Internal sales also increased 3.5 percent compared to the first nine months of fiscal 2020. Reported net income attributable to Patterson Companies, Inc. was $127.2 million, or $1.32 per diluted share, compared to a $20.1 million, or $0.21 per diluted share, in last year's period. Adjusted net income1 attributable to Patterson Companies, Inc., which excludes deal amortization, integration and business restructuring expenses, legal reserve costs, accelerated debt-related costs and an investment gain, totaled $148.4 million, or $1.54 per diluted share. This compares to $106.5 million, or $1.12 per diluted share in the year-ago period, representing a 38 percent increase year-over-year.
Fiscal 2021 Guidance
Due to the continued uncertainty surrounding the COVID-19 pandemic and its impact on business operations, Patterson is not providing fourth-quarter fiscal 2021 financial guidance at this time.
1Non-GAAP Financial Measures
The Reconciliation of GAAP to non-GAAP Measures table appearing behind the accompanying financial information is provided to adjust reported GAAP measures, namely operating income, income before taxes, income tax expense, net income, net income attributable to Patterson Companies, Inc. and diluted earnings per share attributable to Patterson Companies, Inc., for the impact of deal amortization, integration and business restructuring expenses, legal reserve costs, accelerated debt-related costs and an investment gain, along with the related tax effects of these items.
The term “free cash flow” used in this release is defined as net cash used in operating activities less capital expenditures less the one-time benefit from the initiation of our trade accounts receivables facilities plus the collection of deferred purchase price receivables.
In addition, the term “internal sales” used in this release represents net sales adjusted to exclude the impact of foreign currency and changes in product selling relationships. Foreign currency impact represents the difference in results that is attributable to fluctuations in currency exchange rates the company uses to convert results for all foreign entities where the functional currency is not the U.S. dollar. The company calculates the impact as the difference between the current period results translated using the current period currency exchange rates and using the comparable prior period's currency exchange rates. The company believes the disclosure of net sales changes in constant currency provides useful supplementary information to investors in light of significant fluctuations in currency rates.
Management believes that these non-GAAP measures may provide a helpful representation of the company's third-quarter performance and enable comparison of financial results between periods where certain items may vary independent of business performance. These non-GAAP financial measures are presented solely for informational and comparative purposes and should not be regarded as a replacement for corresponding, similarly captioned, GAAP measures.
Third-Quarter Conference Call and Replay
Patterson Companies’ fiscal 2021 third-quarter earnings conference call will start at 10 a.m. Eastern today. Investors can listen to a live webcast of the conference call at www.pattersoncompanies.com. The conference call will be archived on the Patterson Companies website. A replay of the fiscal 2021 third-quarter conference call can be heard for one week at 800-585-8367 and by providing the Conference ID 1612628 when prompted.
About Patterson Companies Inc.
Patterson Companies Inc. (Nasdaq: PDCO) connects dental and animal health customers in North America and the U.K. to the latest products, technologies, services and innovative business solutions that enable operational and professional success. Our comprehensive portfolio, distribution network and supply chain is equaled only by our dedicated, knowledgeable people who deliver unrivalled expertise and unmatched customer service and support.
Learn more: pattersoncompanies.com
This press release contains, and our officers and representatives may from time to time make, certain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including statements regarding future financial performance, and the objectives and expectations of management. Forward-looking statements often include words such as “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “seeks” or words of similar meaning, or future or conditional verbs, such as “will,” “should,” “could” or “may.” Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not place undue reliance on any of these forward-looking statements.
Any number of factors could affect our actual results and cause such results to differ materially from those contemplated by any forward-looking statements, including, but not limited to, the following: the effects of the highly competitive dental and animal health supply markets in which we compete; the COVID-19 pandemic and measures taken in response thereto; general economic conditions, including political and economic uncertainty; risks from disruption to our information systems; our ability to comply with restrictive covenants in our amended credit agreement; our dependence on relationships with sales representatives, service technicians and customers; our ability to realize the long-term strategic benefits of our acquisition of Animal Health International; potential disruption of distribution capabilities, including service issues with third-party shippers; our ability to provide our sales force and customers with the latest technology; our dependence on suppliers for the manufacture and supply of the products we sell; material changes in our purchasing relationship with suppliers; the risk that private label sales could adversely affect our relationships with suppliers; our dependence on positive perceptions of Patterson’s reputation; risks inherent in acquiring other businesses; the risk that our acquired technology or developed technology might not be successful in maintaining or gaining customers; litigation risks, including new or unanticipated litigation developments and new or unanticipated regulatory investigations; changes in consumer preferences; regulatory restrictions; the cyclicality of the livestock market; the outbreak of an infectious disease within the production animal or companion animal population; pressure from animal rights groups; adverse changes in supplier rebates; fluctuations in quarterly financial results; volatility in the price of our stock; risks from the expansion of customer purchasing power; increases in over-the-counter sales of companion animal products; the risks inherent in international operations, including currency fluctuations; the effects of health care reform; failure to comply with regulatory requirements and data privacy laws; cyberattacks or other privacy or data security breaches; the risk of the products we sell becoming obsolete or containing undetected errors; volatility in the financial markets; our dependence on our senior management; our dependence on leadership development and succession planning; disruptions from our enterprise resource planning system; risks associated with shareholder activism; the risk of being required to record impairment charges; the risk of audit by tax authorities; risks associated with interest rate fluctuations; and the risk that our governing documents and Minnesota law may discourage takeovers and business combinations. The order in which these factors appear should not be construed to indicate their relative importance or priority. We caution that these factors may not be exhaustive, accordingly, any forward-looking statements contained herein should not be relied upon as a prediction of actual results.
You should carefully consider these and other relevant factors, including those risk factors in Part I, Item 1A, (“Risk Factors”) in our most recent Form 10-K, as amended and supplemented by our Quarterly Report on Form 10-Q for the quarterly period ended October 24, 2020, and information which may be contained in our other filings with the U.S. Securities and Exchange Commission, or SEC, when reviewing any forward-looking statement. Investors should understand it is impossible to predict or identify all such factors or risks. As such, you should not consider the foregoing list, or the risks identified in our SEC filings, to be a complete discussion of all potential risks or uncertainties.
Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We do not undertake any obligation to release publicly any revisions to any forward-looking statements whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
PATTERSON COMPANIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
(Unaudited)
Three Months Ended
Nine Months Ended
January 23, 2021
January 25, 2020
January 23, 2021
January 25, 2020
Net sales
$
1,551,268
$
1,456,155
$
4,350,273
$
4,203,550
Gross profit
324,541
311,830
898,725
903,378
Operating expenses
262,860
268,014
725,466
861,034
Operating income
61,681
43,816
173,259
42,344
Other income (expense):
Other income, net
4,323
2,307
9,580
34,493
Interest expense
(5,532
)
(16,584
)
(18,604
)
(34,320
)
Income before taxes
60,472
29,539
164,235
42,517
Income tax expense
11,905
6,567
37,640
23,087
Net income
48,567
22,972
126,595
19,430
Net loss attributable to noncontrolling interests
(192
)
(255
)
(631
)
(710
)
Net income attributable to Patterson Companies, Inc.
$
48,759
$
23,227
$
127,226
$
20,140
Earnings per share attributable to Patterson Companies, Inc.:
Basic
$
0.51
$
0.25
$
1.33
$
0.21
Diluted
$
0.50
$
0.24
$
1.32
$
0.21
Weighted average shares:
Basic
95,734
94,267
95,472
94,052
Diluted
96,953
95,021
96,379
94,828
Dividends declared per common share
$
0.26
$
0.26
$
0.78
$
0.78
PATTERSON COMPANIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)
January 23, 2021
April 25, 2020
ASSETS
Current assets:
Cash and cash equivalents
$
155,961
$
77,944
Receivables, net
456,138
416,523
Inventory
838,012
812,194
Prepaid expenses and other current assets
273,119
236,104
Total current assets
1,723,230
1,542,765
Property and equipment, net
224,310
303,725
Operating lease right-of-use assets, net
80,157
79,021
Goodwill and identifiable intangibles, net
428,156
452,229
Long-term receivables, net and other
395,112
337,610
Total assets
$
2,850,965
$
2,715,350
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable
$
677,054
$
862,093
Other accrued liabilities
282,638
182,099
Operating lease liabilities
32,452
30,706
Current maturities of long-term debt
100,750
—
Borrowings on revolving credit
108,000
—
Total current liabilities
1,200,894
1,074,898
Long-term debt
487,850
587,766
Non-current operating lease liabilities
51,648
49,854
Other non-current liabilities
175,968
166,388
Total liabilities
1,916,360
1,878,906
Stockholders' equity
934,605
836,444
Total liabilities and stockholders' equity
$
2,850,965
$
2,715,350
PATTERSON COMPANIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
Nine Months Ended
January 23, 2021
January 25, 2020
Operating activities:
Net income
$
126,595
$
19,430
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization
58,355
61,892
Investment gain
—
(34,334
)
Non-cash employee compensation
25,161
28,661
Accelerated amortization of costs on early repayment of debt
—
8,984
Non-cash losses (gains) and other, net
6,791
—
Change in assets and liabilities:
Receivables
(685,345
)
(380,340
)
Inventory
(12,506
)
(104,494
)
Accounts payable
(199,558
)
151,464
Accrued liabilities
67,503
108,107
Long term receivables
(3,103
)
(6,169
)
Other changes from operating activities, net
11,223
(22,157
)
Net cash used in operating activities
(604,884
)
(168,956
)
Investing activities:
Additions to property and equipment
(21,101
)
(32,872
)
Collection of deferred purchase price receivables
634,499
359,329
Other investing activities
2,493
—
Net cash provided by investing activities
615,891
326,457
Financing activities:
Dividends paid
(50,077
)
(75,522
)
Proceeds from issuance of long-term debt, net
—
296,700
Payments on long-term debt
—
(460,840
)
Draw on revolving credit
108,000
95,000
Other financing activities
2,139
(3,319
)
Net cash provided by (used in) financing activities
60,062
(147,981
)
Effect of exchange rate changes on cash
6,948
1,003
Net change in cash and cash equivalents
78,017
10,523
Cash and cash equivalents at beginning of period
77,944
95,646
Cash and cash equivalents at end of period
$
155,961
$
106,169
PATTERSON COMPANIES, INC.
SALES SUMMARY
(Dollars in thousands)
(Unaudited)
January 23, 2021
January 25, 20201
Total Sales Growth
Foreign Exchange Impact
Other 2
Internal Sales Growth
Three Months Ended
Consolidated net sales
Consumable
$
1,199,102
$
1,090,891
9.9
%
0.4
%
(0.9
)%
10.4
%
Equipment and software
266,519
273,329
(2.5
)
0.1
—
(2.6
)
Value-added services and other
85,647
91,935
(6.8
)
0.1
—
(6.9
)
Total
$
1,551,268
$
1,456,155
6.5
%
0.3
%
(0.7
)%
6.9
%
Dental
Consumable
$
342,561
$
301,599
13.6
%
—
%
—
%
13.6
%
Equipment and software
237,096
252,874
(6.2
)
0.1
—
(6.3
)
Value-added services and other
69,289
72,116
(3.9
)
—
—
(3.9
)
Total
$
648,946
$
626,589
3.6
%
—
%
—
%
3.6
%
Animal Health
Consumable
$
856,541
$
789,292
8.5
%
0.6
%
(1.3
)%
9.2
%
Equipment and software
29,423
20,455
43.8
—
—
43.8
Value-added services and other
8,383
7,538
11.2
1.5
—
9.7
Total
$
894,347
$
817,285
9.4
%
0.6
%
(1.2
)%
10.0
%
Corporate
Value-added services and other
$
7,975
$
12,281
(35.1
)%
—
%
—
%
(35.1
)%
Total
$
7,975
$
12,281
(35.1
)%
—
%
—
%
(35.1
)%
1 Certain sales were reclassified between categories to conform to the current period presentation.
2 Sales of certain products previously recognized on a gross basis were recognized on a net basis during the three and nine months ended January 23, 2021.
PATTERSON COMPANIES, INC.
SALES SUMMARY
(Dollars in thousands)
(Unaudited)
January 23, 2021
January 25, 20201
Total Sales Growth
Foreign Exchange Impact
Other 2
Internal Sales Growth
Nine Months Ended
Consolidated net sales
Consumable
$
3,485,669
$
3,313,556
5.2
%
0.3
%
(0.3
)%
5.2
%
Equipment and software
616,077
621,652
(0.9
)
—
—
(0.9
)
Value-added services and other
248,527
268,342
(7.4
)
0.1
—
(7.5
)
Total
$
4,350,273
$
4,203,550
3.5
%
0.2
%
(0.2
)%
3.5
%
Dental
Consumable
$
957,013
$
909,638
5.2
%
—
%
—
%
5.2
%
Equipment and software
548,194
566,750
(3.3
)
—
—
(3.3
)
Value-added services and other
205,782
215,940
(4.7
)
—
—
(4.7
)
Total
$
1,710,989
$
1,692,328
1.1
%
—
%
—
%
1.1
%
Animal Health
Consumable
$
2,528,656
$
2,403,918
5.2
%
0.4
%
(0.4
)%
5.2
%
Equipment and software
67,883
54,902
23.6
—
—
23.6
Value-added services and other
24,138
24,192
(0.2
)
1.0
—
(1.2
)
Total
$
2,620,677
$
2,483,012
5.5
%
0.4
%
(0.4
)%
5.5
%
Corporate
Value-added services and other
$
18,607
$
28,210
(34.0
)%
—
%
—
%
(34.0
)%
Total
$
18,607
$
28,210
(34.0
)%
—
%
—
%
(34.0
)%
1 Certain sales were reclassified between categories to conform to the current period presentation.
2 Sales of certain products previously recognized on a gross basis were recognized on a net basis during the three and nine months ended January 23, 2021.
PATTERSON COMPANIES, INC.
OPERATING INCOME BY SEGMENT
(In thousands)
(Unaudited)
Three Months Ended
Nine Months Ended
January 23, 2021
January 25, 2020
January 23, 2021
January 25, 2020
Operating income (loss)
Dental
$
61,291
$
48,822
$
172,017
$
135,458
Animal Health
20,615
13,438
55,605
51,236
Corporate
(20,225
)
(18,444
)
(54,363
)
(144,350
)
Total
$
61,681
$
43,816
$
173,259
$
42,344
PATTERSON COMPANIES, INC.
RECONCILIATION OF GAAP TO NON-GAAP MEASURES
(Dollars in thousands, except per share amounts)
(Unaudited)
For the three months ended January 23, 2021
GAAP
Deal amortization
Integration and business restructuring expenses
Legal reserve costs
Accelerated debt-related costs
Investment gain
Non-GAAP
Operating income
$
61,681
$
9,238
$
—
$
—
$
—
$
—
$
70,919
Other income (expense), net
(1,209
)
—
—
—
—
—
(1,209
)
Income before taxes
60,472
9,238
—
—
—
—
69,710
Income tax expense
11,905
2,196
—
—
—
—
14,101
Net income
48,567
7,042
—
—
—
—
55,609
Net loss attributable to noncontrolling interests
(192
)
—
—
—
—
—
(192
)
Net income attributable to Patterson Companies, Inc.
$
48,759
$
7,042
$
—
$
—
$
—
$
—
$
55,801
Diluted earnings per share attributable to Patterson Companies, Inc.*
$
0.50
$
0.07
$
—
$
—
$
—
$
—
$
0.58
Operating income as a % of sales
4.0
%
4.6
%
Effective tax rate
19.7
%
20.2
%
For the three months ended January 25, 2020
GAAP
Deal amortization
Integration and business restructuring expenses
Legal reserve costs
Accelerated debt-related costs
Investment gain
Non-GAAP
Operating income
$
43,816
$
9,267
$
7,714
$
2,288
$
—
$
—
$
63,085
Other income (expense), net
(14,277
)
—
—
—
8,984
—
(5,293
)
Income before taxes
29,539
9,267
7,714
2,288
8,984
—
57,792
Income tax expense
6,567
2,200
1,928
572
2,246
—
13,513
Net income
22,972
7,067
5,786
1,716
6,738
—
44,279
Net loss attributable to noncontrolling interests
(255
)
—
—
—
—
—
(255
)
Net income attributable to Patterson Companies, Inc.
$
23,227
$
7,067
$
5,786
$
1,716
$
6,738
$
—
$
44,534
Diluted earnings per share attributable to Patterson Companies, Inc.*
$
0.24
$
0.07
$
0.06
$
0.02
$
0.07
$
—
$
0.47
Operating income as a % of sales
3.0
%
4.3
%
Effective tax rate
22.2
%
23.4
%
* May not sum due to rounding
PATTERSON COMPANIES, INC.
RECONCILIATION OF GAAP TO NON-GAAP MEASURES
(Dollars in thousands, except per share amounts)
(Unaudited)
For the nine months ended January 23, 2021
GAAP
Deal amortization
Integration and business restructuring expenses
Legal reserve costs
Accelerated debt-related costs
Investment gain
Non-GAAP
Operating income
$
173,259
$
27,741
$
—
$
—
$
—
$
—
$
201,000
Other income (expense), net
(9,024
)
—
—
—
—
—
(9,024
)
Income before taxes
164,235
27,741
—
—
—
—
191,976
Income tax expense
37,640
6,596
—
—
—
—
44,236
Net income
126,595
21,145
—
—
—
—
147,740
Net loss attributable to noncontrolling interests
(631
)
—
—
—
—
—
(631
)
Net income attributable to Patterson Companies, Inc.
$
127,226
$
21,145
$
—
$
—
$
—
$
—
$
148,371
Diluted earnings per share attributable to Patterson Companies, Inc.*
$
1.32
$
0.22
$
—
$
—
$
—
$
—
$
1.54
Operating income as a % of sales
4.0
%
4.6
%
Effective tax rate
22.9
%
23.0
%
For the nine months ended January 25, 2020
GAAP
Deal amortization
Integration and business restructuring expenses
Legal reserve costs‡
Accelerated debt-related costs
Investment gain
Non-GAAP
Operating income
$
42,344
$
27,758
$
13,461
$
81,254
$
—
$
—
$
164,817
Other income (expense), net
173
—
—
—
9,943
(34,334
)
(24,218
)
Income before taxes
42,517
27,758
13,461
81,254
9,943
(34,334
)
140,599
Income tax expense
23,087
6,601
3,370
7,113
2,486
(7,884
)
34,773
Net income
19,430
21,157
10,091
74,141
7,457
(26,450
)
105,826
Net loss attributable to noncontrolling interests
(710
)
—
—
—
—
—
(710
)
Net income attributable to Patterson Companies, Inc.
$
20,140
$
21,157
$
10,091
$
74,141
$
7,457
$
(26,450
)
$
106,536
Diluted earnings per share attributable to Patterson Companies, Inc.*
$
0.21
$
0.22
$
0.11
$
0.78
$
0.08
$
(0.28
)
$
1.12
Operating income as a % of sales
1.0
%
3.9
%
Effective tax rate
54.3
%
24.7
%
‡ Includes costs and expenses incurred in the first quarter of fiscal 2020 of $17,666 related to the settlement of litigation with SourceOne Dental, Inc., costs and expenses incurred in the second quarter of fiscal 2020 of $58,300 related to the then-probable settlement of litigation with the U.S. Attorney's Office for the Western District of Virginia and $5,288 related to other legal proceedings.
* May not sum due to rounding
PATTERSON COMPANIES, INC.
FREE CASH FLOW
(In thousands)
(Unaudited)
Nine Months Ended
January 23, 2021
January 25, 2020
Net cash used in operating activities
$
(604,884
)
$
(168,956
)
Additions to property and equipment
(21,101
)
(32,872
)
Collection of deferred purchase price receivables
634,499
359,329
Impact of trade account receivables facility
—
(29,000
)
Free cash flow
$
8,514
$
128,501
View source version on businesswire.com: https://www.businesswire.com/news/home/20210303005290/en/
INVESTOR CONTACT: John M. Wright, Investor Relations Patterson Companies Inc. 651.686.1364 investor.relations@pattersoncompanies.com
MEDIA CONTACT: Patterson Corporate Communications Patterson Companies Inc. 651.905.3349 corporate.communications@pattersoncompanies.com
WEB: pattersoncompanies.com
1 Year Patterson Companies Chart |
1 Month Patterson Companies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions